Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide COA documentation is available through our COA Library
Related Stories Newer GLP-1 medications may reduce alcohol-related hospitalization risk Generic semaglutide could improve diabetes treatment affordability in Canada Alcohol use during pregnancy increased in the United States from 2011 through 2024 Simultaneously, a growing body of evidence suggests that Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) are capable of crossing the blood-brain barrier (BBB) and interacting with the brain's reward and dopamine signaling regions, leading researchers to hypothesize that these originally weight-management-centric drugs could be used to address addictive behaviors, specifically regarding the suppression of ethanol-seeking triggers
References Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications | Health Affairs CMSs $40B GLP-1 Proposal Offers Leeway for Part D Plans to Define Obe AIS Health - MMIT Medicare & Medicaid Services CMS Proposes Changes to Medicare Adv Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Semaglutide is marketed under the brand names Ozempic (primarily for diabetes) and Wegovy (for weight loss)
Retatrutides GLP-1 arm is intentionally softer than semaglutides, which is why nausea profiles diverge at matched weight loss
